```html

Coarctation of the Aorta – Comprehensive Medical Guide

Overview

Coarctation of the aorta (CoA) is a congenital narrowing of a short segment of the aorta, most commonly just distal to the ductus arteriosus (the “juxtaductal” area). This narrowing creates a pressure gradient that forces the heart to pump harder to move blood past the obstruction.

Who it affects

• Primarily a birth defect—about 6‑8 per 10,000 live births worldwide.
• Occurs more often in males (≈2:1 male‑to‑female ratio).
• ≈50 % of cases are associated with other congenital heart lesions (e.g., bicuspid aortic valve, ventricular septal defect).

Prevalence & burden

• In the United States, ≈1.5 million adults live with repaired or unrepaired coarctation, according to the Adult Congenital Heart Association.
• Survival has dramatically improved: >90 % of children diagnosed today survive to adulthood with appropriate treatment.

Symptoms

Symptoms vary with the severity of the narrowing and the age at diagnosis. Some patients are asymptomatic until adulthood.

Infants (severe coarctation)

• Respiratory distress – rapid breathing, grunting.
• Failure to thrive – poor weight gain despite adequate feeding.
• Cold extremities – especially lower limbs.
• Shock – pale, limp, low blood pressure if the ductus closes suddenly.

Children & Adolescents (moderate coarctation)

• Headaches or dizziness, especially with exertion.
• Claudication – leg pain or cramping after walking.
• Upper‑body hypertension (high blood pressure in arms) with normal or low pressure in legs.
• Heart murmur (a systolic ejection murmur best heard on the back between the scapulae).
• Reduced exercise tolerance.

Adults (repaired or unrepaired)

• Persistent upper‑body hypertension.
• Chest pain or pressure, particularly during activity.
• Shortness of breath on exertion.
• Fatigue or light‑headedness.
• Peripheral edema (swelling) of the legs if heart failure develops.

Causes and Risk Factors

Primary cause – developmental anomaly

CoA results from abnormal development of the aortic wall during fetal life. The exact mechanism is not fully understood, but hypotheses include:

• Abnormal constriction of the ductus arteriosus tissue.
• Disruption of signaling pathways (e.g., NOTCH, VEGF) that regulate aortic wall growth.

Genetic and syndromic associations

• Bicuspid aortic valve – present in up to 50 % of CoA patients.
• Turner syndrome – females with this chromosomal disorder have a 10‑20 % risk of CoA.
• Williams‑Beuren syndrome, Noonan syndrome, and other rare genetic conditions.

Risk factors for delayed diagnosis or complications

• Male sex (higher prevalence).
• Associated cardiac anomalies that divert attention from the aortic narrowing.
• Limited access to prenatal or early childhood cardiac imaging.
• Family history of congenital heart disease.

Diagnosis

Early detection is crucial. Diagnosis combines physical examination with imaging and sometimes invasive testing.

Physical exam clues

• Blood pressure discrepancy: ↑ systolic BP in arms vs. legs (difference >20 mmHg).
• Weak or delayed femoral pulses (“radio‑femoral delay”).
• Continuous murmur over the back.

Imaging & tests

Test	What it shows	Typical use
Echocardiography (transthoracic)	Location & severity of narrowing, associated lesions, flow gradient.	First‑line in infants and children.
Cardiac MRI (CMR)	Detailed anatomy, collateral vessels, ventricular function.	Adults, pre‑operative planning.
CT angiography	High‑resolution view of aortic arch and surrounding structures.	When MRI contraindicated.
Cardiac catheterization	Direct pressure measurements, angiographic anatomy, option for balloon angioplasty.	Complex cases or when intervention is planned.
Chest X‑ray	“Figure‑3 sign” or rib notching from collateral circulation.	Screening clue, not definitive.

Screening for associated conditions

• Electrocardiogram (ECG) – looks for left ventricular hypertrophy.
• Genetic testing – indicated when Turner syndrome or other syndromes are suspected.

Treatment Options

Therapy aims to relieve the obstruction, control blood pressure, and prevent long‑term complications.

Medical management (pre‑ and post‑procedure)

• Antihypertensives – beta‑blockers, ACE inhibitors, or calcium‑channel blockers are first‑line to control upper‑body hypertension.
• Diuretics may be added if heart failure develops.
• Lifestyle: low‑salt diet, regular aerobic activity (as tolerated), weight control.

Interventional procedures

1. Balloon angioplasty – a catheter‑mounted balloon is inflated at the site of narrowing. Often combined with a stent in older children and adults.
2. Stent implantation – expands the aortic lumen and reduces restenosis risk. Covered stents are preferred when the aortic wall is fragile.
3. Surgical repair – indicated for severe or long‑segment coarctation, recoarctation after previous catheter treatment, or associated cardiac defects.
   • Resection with end‑to‑end anastomosis.
   • Patch‑aortoplasty (using synthetic or autologous tissue).
   • Subclavian flap or “extended” repair for very young infants.

Decision factors

• Age & size of the patient.
• Anatomy of the narrowing (length, location, vessel wall quality).
• Presence of other cardiac lesions.
• Institutional expertise – some centers specialize in catheter‑based therapy, others in neonatal surgery.

Post‑procedure care

• Serial blood‑pressure monitoring (every 6–12 months).
• Imaging follow‑up (echocardiogram or MRI) to detect restenosis.
• Lifelong cardiology follow‑up—most patients need lifelong surveillance.

Living with Coarctation of the Aorta

Daily management tips

• Blood‑pressure checks – measure in both arms and legs when possible; keep a log.
• Medication adherence – never skip antihypertensives; discuss side‑effects with your provider.
• Exercise – moderate aerobic activity (walking, swimming) is safe for most; avoid heavy lifting or isometric exercise if hypertension is uncontrolled.
• Pregnancy considerations – Women with repaired CoA should have pre‑conception counseling; uncontrolled hypertension increases risk for aortic dissection.
• Vaccinations – flu and pneumococcal vaccines reduce infection‑related cardiac stress.
• Dental hygiene – maintain good oral health; infections can precipitate endocarditis in patients with residual lesions.

Psychosocial aspects

Living with a congenital heart condition can cause anxiety, especially during life milestones (college, marriage, pregnancy). Access to a cardiac rehab program, counseling, or support groups (e.g., Adult Congenital Heart Association) can improve quality of life.

Prevention

Because CoA is congenital, primary prevention is limited, but certain steps can reduce the risk of complications and improve outcomes.

• Pre‑conception & prenatal care – maternal folic acid supplementation and avoidance of teratogens have been linked to lower rates of congenital heart defects overall.
• Early detection – routine newborn cardiac screening (pulse oximetry, cardiac auscultation) can identify severe cases before ductal closure.
• Control of hypertension throughout life to prevent aortic wall stress and aneurysm formation.
• Regular follow‑up – attending scheduled cardiology visits and imaging reduces the chance of unnoticed recoarctation.

Complications

If left untreated or poorly managed, coarctation can lead to serious health problems.

• Systemic hypertension – the most common long‑term issue; increases risk of stroke, myocardial infarction, and kidney disease.
• Aortic aneurysm or dissection – especially proximal to the repair site; risk rises after age 40.
• Left ventricular hypertrophy (LVH) and heart failure – chronic pressure overload strains the heart.
• Bacterial endocarditis – rare but higher risk when residual turbulent flow persists.
• Re‑coarctation – restenosis occurs in 10‑30 % of repaired patients, more often after balloon angioplasty.
• Peripheral vascular disease – collateral vessels can become a source of chronic leg claudication.

When to Seek Emergency Care

References

• Mayo Clinic. “Coarctation of the aorta.” Mayoclinic.org. Accessed May 2026.
• American Heart Association. “Congenital Heart Defects.” heart.org.
• National Institutes of Health, National Heart, Lung, and Blood Institute. “Coarctation of the Aorta.” nih.gov. 2023.
• Cleveland Clinic. “Coarctation of the Aorta – Treatment Options.” clevelandclinic.org.
• World Health Organization. “Congenital heart disease.” 2022 fact sheet. who.int.
• García‑Pérez et al. “Long‑term outcomes after coarctation repair: a 25‑year review.” *Journal of Thoracic and Cardiovascular Surgery*, 2021; 162(4):1245‑1252.

```